3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 1/2
2
Phase 1
2
Phase 4
1
Phase 3
1
Phase 2/3
1
Status
Completed
26
Recruiting
9
Active not recruiting
8
Terminated
5
Unknown
4
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Breast Neoplasms
1
Interventions
Capecitabine
25
Oxaliplatin
24
Paclitaxel
23
Gemcitabine
21
Cisplatin
21
Fluorouracil
20
Carboplatin
18
Drug Therapy
17
Docetaxel
17
pembrolizumab
15
Leucovorin
15
Irinotecan
15
Radiotherapy
12
tislelizumab
11
Injections
10
Radiation
9
Pemetrexed
9
Magnetic Resonance Spectroscopy
9
Bevacizumab
9
toripalimab
8
Cetuximab
8
Surgical Procedures, Operative
7
Specimen Handling
7
Radiotherapy, Intensity-Modulated
7
Azacitidine
7
venetoclax
6
sintilimab
6
atezolizumab
6
Topotecan
6
Cyclophosphamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
Everolimus
×
Clear all
NCT07407517
2026-02-12
POLARIS
Fudan University
Phase 3
Not yet recruiting
904 enrolled